At the Lily Foundation, we are committed to finding a cure for Mitochondrial Disease through funding high quality medical research. It is vital that funds raised through the generosity of our donors are directed towards research, we believe this will give us the best chance of achieving this goal.
The Lily Foundation is an NIHR non-commercial partner, which means eligible funding streams are automatically eligible for NIHR Clinical Research Network (CRN) support and therefore entitled to access NHS support via the NIHR Clinical Research Network.
Call For Applications - Treatments for Mitochondrial Disease
Lily research grants will be offered to academic researchers and institutions that can demonstrate they are committed to discovering innovative treatments for Mitochondrial Disease. Clinical and preclinical treatment studies will be considered, provided they could realistically be expected to translate to clinical practice. Treatments are defined as reducing symptoms of Mitochondrial Disease, improving quality of life or lengthening lifespan of patients.
We are committed to investing a minimum of £200,000/year, for the next 3 years, towards research to develop new treatments for Mitochondrial Disease.
Call: Treatments for Mitochondrial Disease 17/18
Opening Date: Monday 2nd October 2017 - 9am
Closing Date: Friday 1st December 2017 - 5pm
Who can apply?
Any UK academic institution. Principal investigators should have a permanent, open-ended or long-term rolling contract, salaried by a UK-based academic/research organisation.
We will fund 12-24 month research projects, up to a maximum value of £100,000. We will consider funding projects outside this time frame, only if they could lead to significant/direct patient benefit. We are particularly interested in encouraging applicants to apply for 12-18 month pilot funding or efficacy studies, to develop innovative concepts, with budgets of approximate £50-75,000.
Projects should include salary costs and consumables but no large items of equipment (£10,000 max).
How to apply?
Lily grant applicants should prepare a submission covering 5 key areas:
- abstract on the potential treatment being investigated written in layman’s terms (max 100 words);
- objectives, methodology and plan of investigation with clear timeline (max 2 pages of A4);
- summary of benefit to patients with mitochondrial disease (max 500 words);
- full costings and justification (max 1 page of A4);
- research environment & supervisory team (max 500 words); please attach CVs of all applicants (max 2 pages to include details of current research funding and 1 page of up to 10 recent and relevant publications.)
Please note that applications which do not follow the prescribed format, will not be accepted for review.
Applications will be evaluated by our international expert peer review panel, based on the following criteria:
- contribution to treatment of mitochondrial disease & direct patient benefit
- scientific merit/ innovation, soundness of methodology & feasibility of achieving outcomes
- budget details (reasonable, justified and potential value of investment to The Lily Foundation)
- track record of investigator(s) & quality of research environment to perform work efficiently/accurately
Completed applications should be emailed to [email protected]
Decisions will be announced in early March 2018.